Macy L Stockdill1, J Nicholas Dionne-Odom1, Rachel Wells1, Deborah Ejem1, Andres Azuero1, Konda Keebler1, Elizabeth Sockwell1, Sheri Tims1, Kathryn L Burgio2, Sally Engler1, Raegan Durant3, Salpy V Pamboukian4, Jose Tallaj4, Keith M Swetz2, Elizabeth Kvale5, Rodney Tucker5, Marie Bakitas6. 1. School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA. 2. Division of Gerontology, Department of Medicine, Geriatrics, Palliative Care, University of Alabama at Birmingham, Birmingham, AL, USA. 3. Division of Preventative Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. 4. Division of Cardiovascular Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. 5. Department of Medicine, Dell Medical School, University of Texas at Austin, Austin, TX, USA. 6. Division of Gerontology, Geriatrics, and Palliative Care, Department of Medicine, School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.
Abstract
BACKGROUND: Palliative care trial recruitment of African Americans (AAs) is a formidable research challenge. OBJECTIVES: Examine AA clinical trial recruitment and enrollment in a palliative care randomized controlled trial (RCT) for heart failure (HF) patients and compare patient baseline characteristics to other HF palliative care RCTs. METHODS: This is a descriptive analysis the ENABLE CHF-PC (Educate, Nurture, Advise, Before Life Ends: Comprehensive Heartcare for Patients and Caregivers) RCT using bivariate statistics to compare racial and patient characteristics and differences through recruitment stages. We then compared the baseline sample characteristics among three palliative HF trials. RESULTS: Of 785 patients screened, 566 eligible patients with NYHA classification III-IV were approached; 461 were enrolled and 415 randomized (AA = 226). African Americans were more likely to consent than Caucasians (55%; P FDR = .001), were younger (62.7 + 8; P FDR = .03), had a lower ejection fraction (39.1 + 15.4; PFDR = .03), were more likely to be single (P FDR = .001), and lack an advanced directive (16.4%; P FDR < .001). AAs reported higher goal setting (3.3 + 1.3; P FDR = .007), care coordination (2.8 + 1.3; P FDR = .001) and used more "denial" coping strategies (0.8 + 1; P FDR = .001). Compared to two recent HF RCTs, the ENABLE CHF-PC sample had a higher proportion of AAs and higher baseline KCCQ clinical summary scores. CONCLUSION: ENABLE CHF-PC has the highest reported recruitment rate and proportion of AAs in a palliative clinical trial to date. Community-based recruitment partnerships, recruiter training, ongoing communication with recruiters and clinician co-investigators, and recruiter racial concordance likely contributed to successful recruitment of AAs. These important insights provide guidance for design of future HF palliative RCTs. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02505425.
BACKGROUND: Palliative care trial recruitment of African Americans (AAs) is a formidable research challenge. OBJECTIVES: Examine AA clinical trial recruitment and enrollment in a palliative care randomized controlled trial (RCT) for heart failure (HF) patients and compare patient baseline characteristics to other HF palliative care RCTs. METHODS: This is a descriptive analysis the ENABLE CHF-PC (Educate, Nurture, Advise, Before Life Ends: Comprehensive Heartcare for Patients and Caregivers) RCT using bivariate statistics to compare racial and patient characteristics and differences through recruitment stages. We then compared the baseline sample characteristics among three palliative HF trials. RESULTS: Of 785 patients screened, 566 eligible patients with NYHA classification III-IV were approached; 461 were enrolled and 415 randomized (AA = 226). African Americans were more likely to consent than Caucasians (55%; P FDR = .001), were younger (62.7 + 8; P FDR = .03), had a lower ejection fraction (39.1 + 15.4; PFDR = .03), were more likely to be single (P FDR = .001), and lack an advanced directive (16.4%; P FDR < .001). AAs reported higher goal setting (3.3 + 1.3; P FDR = .007), care coordination (2.8 + 1.3; P FDR = .001) and used more "denial" coping strategies (0.8 + 1; P FDR = .001). Compared to two recent HF RCTs, the ENABLE CHF-PC sample had a higher proportion of AAs and higher baseline KCCQ clinical summary scores. CONCLUSION: ENABLE CHF-PC has the highest reported recruitment rate and proportion of AAs in a palliative clinical trial to date. Community-based recruitment partnerships, recruiter training, ongoing communication with recruiters and clinician co-investigators, and recruiter racial concordance likely contributed to successful recruitment of AAs. These important insights provide guidance for design of future HF palliative RCTs. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02505425.
Authors: Joseph G Rogers; Chetan B Patel; Robert J Mentz; Bradi B Granger; Karen E Steinhauser; Mona Fiuzat; Patricia A Adams; Adam Speck; Kimberly S Johnson; Arun Krishnamoorthy; Hongqiu Yang; Kevin J Anstrom; Gwen C Dodson; Donald H Taylor; Jerry L Kirchner; Daniel B Mark; Christopher M O'Connor; James A Tulsky Journal: J Am Coll Cardiol Date: 2017-07-18 Impact factor: 24.094
Authors: Suzanne V Arnold; Zhuokai Li; Sreekanth Vemulapalli; Suzanne J Baron; Michael J Mack; Andrzej S Kosinski; Matthew R Reynolds; James B Hermiller; John S Rumsfeld; David J Cohen Journal: JAMA Cardiol Date: 2018-12-01 Impact factor: 14.676
Authors: Mercedes R Carnethon; Jia Pu; George Howard; Michelle A Albert; Cheryl A M Anderson; Alain G Bertoni; Mahasin S Mujahid; Latha Palaniappan; Herman A Taylor; Monte Willis; Clyde W Yancy Journal: Circulation Date: 2017-10-23 Impact factor: 29.690
Authors: Ahsan M Arozullah; Paul R Yarnold; Charles L Bennett; Robert C Soltysik; Michael S Wolf; Rosario M Ferreira; Shoou-Yih D Lee; Stacey Costello; Adil Shakir; Caroline Denwood; Fred B Bryant; Terry Davis Journal: Med Care Date: 2007-11 Impact factor: 2.983
Authors: J Nicholas Dionne-Odom; Alan Kono; Jennifer Frost; Lisa Jackson; Daphne Ellis; Ali Ahmed; Andres Azuero; Marie Bakitas Journal: J Palliat Med Date: 2014-07-29 Impact factor: 2.947
Authors: Rachel Wells; James Nicholas Dionne-Odom; Andres Azuero; Harleah Buck; Deborah Ejem; Kathryn L Burgio; Macy L Stockdill; Rodney Tucker; Salpy V Pamboukian; Jose Tallaj; Sally Engler; Konda Keebler; Sheri Tims; Raegan Durant; Keith M Swetz; Marie Bakitas Journal: J Pain Symptom Manage Date: 2021-02-05 Impact factor: 5.576